2,610,947 Shares in Option Care Health, Inc. $OPCH Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) during the first quarter, HoldingsChannel reports. The firm purchased 2,610,947 shares of the company’s stock, valued at approximately $70,287,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of OPCH. V Square Quantitative Management LLC acquired a new stake in shares of Option Care Health in the fourth quarter valued at approximately $25,000. Advisory Services Network LLC acquired a new position in shares of Option Care Health during the 3rd quarter worth approximately $35,000. McIlrath & Eck LLC bought a new stake in Option Care Health in the 2nd quarter valued at $37,000. Caitong International Asset Management Co. Ltd bought a new stake in Option Care Health in the 3rd quarter valued at $38,000. Finally, Quarry LP lifted its holdings in Option Care Health by 502.7% during the 3rd quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after purchasing an additional 1,292 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Performance

Shares of OPCH traded down $0.10 during midday trading on Friday, reaching $21.57. 1,803,038 shares of the stock were exchanged, compared to its average volume of 2,424,430. Option Care Health, Inc. has a twelve month low of $18.01 and a twelve month high of $36.80. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The company has a market cap of $3.39 billion, a P/E ratio of 16.72, a PEG ratio of 1.20 and a beta of 0.65. The stock’s 50 day simple moving average is $21.03 and its 200 day simple moving average is $27.87.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.39 billion. During the same period in the prior year, the company posted $0.40 earnings per share. Option Care Health’s revenue was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, sell-side analysts expect that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Insider Activity

In related news, Director Timothy P. Sullivan acquired 24,154 shares of the company’s stock in a transaction on Thursday, May 7th. The stock was purchased at an average cost of $20.69 per share, with a total value of $499,746.26. Following the acquisition, the director directly owned 73,383 shares of the company’s stock, valued at approximately $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. bought 36,610 shares of Option Care Health stock in a transaction dated Monday, May 4th. The shares were bought at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the completion of the acquisition, the director owned 450,000 shares in the company, valued at $9,634,500. This represents a 8.86% increase in their position. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders acquired 73,264 shares of company stock worth $1,548,316. Corporate insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. The Goldman Sachs Group assumed coverage on shares of Option Care Health in a research report on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective for the company. Stephens set a $30.00 target price on shares of Option Care Health in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. TD Cowen lowered their price target on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Finally, UBS Group reissued a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.